Integra Lifesciences (IART) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $13.21, -2.37% vs the prior close of $13.53.
- Volume 830.98K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IART dips 2.4% to $13.21. Closed at $13.21, -2.37% vs the prior close of $13.53. Day range $13.10–$13.83, opened at $13.65.
IART daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IART dips 2.4% to $13.21
- Closed at $13.21, -2.37% vs the prior close of $13.53. Day range $13.10–$13.83, opened at $13.65.
- Volume was 830.98K shares, 0.9x its 50-day average of 887.15K.
- Price is -16.6% vs its 50-day average ($15.83) and -6.2% vs its 200-day average ($14.08).
- 52-week range $8.70–$20.49; today's close sits at 38% of that range, 35.5% below the 52-week high.
Oct 15, 2026 — IART rises 2.7% to $13.53
- Closed at $13.53, +2.66% vs the prior close of $13.18. Day range $13.29–$13.64, opened at $13.38.
- Volume was 1.33M shares, 1.5x its 50-day average of 872.59K.
- Price is -15.0% vs its 50-day average ($15.91) and -3.9% vs its 200-day average ($14.08).
- 52-week range $8.70–$20.49; today's close sits at 41% of that range, 34.0% below the 52-week high.
Oct 14, 2026 — IART slides 4.8% to $13.18
- Closed at $13.18, -4.84% vs the prior close of $13.85. Day range $12.92–$13.79, opened at $13.45.
- Volume was 1.11M shares, 1.3x its 50-day average of 865.45K.
- Price is -17.6% vs its 50-day average ($15.99) and -6.4% vs its 200-day average ($14.08).
- 52-week range $8.70–$20.49; today's close sits at 38% of that range, 35.7% below the 52-week high.
Oct 13, 2026 — IART dips 0.9% to $13.85
- Closed at $13.85, -0.93% vs the prior close of $13.98. Day range $13.66–$14.28, opened at $14.05.
- Volume was 818.80K shares, 0.9x its 50-day average of 874.65K.
- Price is -13.9% vs its 50-day average ($16.09) and -1.6% vs its 200-day average ($14.07).
- 52-week range $8.70–$20.49; today's close sits at 44% of that range, 32.4% below the 52-week high.
Oct 12, 2026 — IART jumps 4.0% to $13.98, 3 up days in a row
- Closed at $13.98, +4.02% vs the prior close of $13.44. Day range $13.42–$14.03, opened at $13.43.
- Volume was 893.70K shares, 1.0x its 50-day average of 875.48K.
- Price is -13.5% vs its 50-day average ($16.17) and -0.6% vs its 200-day average ($14.07).
- 52-week range $8.70–$20.49; today's close sits at 45% of that range, 31.8% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — IART ends flat (+0.2%) to $13.44
- Closed at $13.44, +0.22% vs the prior close of $13.41. Day range $13.23–$13.86, opened at $13.38.
- Volume was 1.23M shares, 1.4x its 50-day average of 885.07K.
- Price is -17.2% vs its 50-day average ($16.22) and -4.4% vs its 200-day average ($14.06).
- 52-week range $8.70–$20.49; today's close sits at 40% of that range, 34.4% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — IART jumps 3.2% to $13.41
- Closed at $13.41, +3.15% vs the prior close of $13.00. Day range $12.83–$13.44, opened at $12.86.
- Volume was 1.46M shares, 1.6x its 50-day average of 906.90K.
- Price is -17.7% vs its 50-day average ($16.30) and -4.6% vs its 200-day average ($14.06).
- 52-week range $8.70–$20.49; today's close sits at 40% of that range, 34.6% below the 52-week high.
Oct 7, 2026 — IART dips 2.4% to $13.00
- Closed at $13.00, -2.40% vs the prior close of $13.32. Day range $12.98–$13.46, opened at $13.19.
- Volume was 1.41M shares, 1.6x its 50-day average of 902.05K.
- Price is -20.5% vs its 50-day average ($16.36) and -7.5% vs its 200-day average ($14.05).
- 52-week range $8.70–$20.49; today's close sits at 36% of that range, 36.6% below the 52-week high.
Oct 6, 2026 — IART ends flat (+0.2%) to $13.32
- Closed at $13.32, +0.23% vs the prior close of $13.29. Day range $12.88–$13.51, opened at $13.46.
- Volume was 1.37M shares, 1.5x its 50-day average of 894.97K.
- Price is -19.2% vs its 50-day average ($16.49) and -5.2% vs its 200-day average ($14.05).
- 52-week range $8.70–$20.49; today's close sits at 39% of that range, 35.0% below the 52-week high.
Oct 5, 2026 — IART jumps 4.8% to $13.29 on 2.1x normal volume
- Closed at $13.29, +4.81% vs the prior close of $12.68. Day range $12.35–$13.49, opened at $12.65.
- Volume was 1.86M shares, 2.1x its 50-day average of 875.82K — unusually heavy trading.
- Price is -20.0% vs its 50-day average ($16.62) and -5.4% vs its 200-day average ($14.05).
- 52-week range $8.70–$20.49; today's close sits at 39% of that range, 35.1% below the 52-week high.
Oct 2, 2026 — IART slides 21.2% to $12.68, a 3-month low on 3.2x normal volume
- Closed at $12.68, -21.19% vs the prior close of $16.09. Day range $12.63–$14.00, opened at $13.31.
- Volume was 2.69M shares, 3.2x its 50-day average of 834.12K — unusually heavy trading.
- Price is -24.3% vs its 50-day average ($16.75) and -9.8% vs its 200-day average ($14.05).
- 52-week range $8.70–$20.49; today's close sits at 34% of that range, 38.1% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
IART latest news & SEC filings
Every SEC filing by or about IART in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 28, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $418.76M (prior year $415.61M) (+0.8% vs Jun 30, 2025)
- Net income: $4.48M (prior year -$484.07M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.06 (prior year -$6.31) (swung to profit vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade IART
- Last results release: Oct 2, 2026 (8-K Item 2.02). Previous ones: Jul 29, 2026, May 5, 2026, Feb 26, 2026. Based on that rhythm, the next report is likely around Jan 1, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.27% (largest 21.2%). That is a volatile stock.
- Liquidity: about 1.08M shares (≈$14.28M) trade per day on average.
- 52-week position: $13.21 vs a range of $8.70–$20.49 (38% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Jeffrey A Graves bought 9,000 shares on Nov 5, 2025.
- Latest filings: 8-K Oct 9, 2026; 8-K Oct 2, 2026; 8-K Sep 8, 2026.
- Share count: 77.77M shares outstanding (Jul 28, 2026), -0.2% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
IART market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 13.65 | 13.83 | 13.10 | 13.21 | 830.98K |
| Oct 15, 2026 | 13.38 | 13.64 | 13.29 | 13.53 | 1.33M |
| Oct 14, 2026 | 13.45 | 13.79 | 12.92 | 13.18 | 1.11M |
| Oct 13, 2026 | 14.05 | 14.28 | 13.66 | 13.85 | 818.80K |
| Oct 12, 2026 | 13.43 | 14.03 | 13.42 | 13.98 | 893.70K |
| Oct 9, 2026 | 13.38 | 13.86 | 13.23 | 13.44 | 1.23M |
| Oct 8, 2026 | 12.86 | 13.44 | 12.83 | 13.41 | 1.46M |
| Oct 7, 2026 | 13.19 | 13.46 | 12.98 | 13.00 | 1.41M |
| Oct 6, 2026 | 13.46 | 13.51 | 12.88 | 13.32 | 1.37M |
| Oct 5, 2026 | 12.65 | 13.49 | 12.35 | 13.29 | 1.86M |
| Oct 2, 2026 | 13.31 | 14.00 | 12.63 | 12.68 | 2.69M |
| Oct 1, 2026 | 16.21 | 16.45 | 15.88 | 16.09 | 652.90K |
| Sep 30, 2026 | 16.67 | 16.67 | 16.14 | 16.28 | 768.90K |
| Sep 29, 2026 | 16.27 | 16.77 | 15.80 | 16.64 | 1.01M |
| Sep 28, 2026 | 16.04 | 16.27 | 15.86 | 16.27 | 479.00K |
| Sep 25, 2026 | 15.88 | 16.21 | 15.74 | 16.12 | 539.00K |
| Sep 24, 2026 | 15.67 | 15.91 | 15.49 | 15.88 | 759.50K |
| Sep 23, 2026 | 15.88 | 16.26 | 15.38 | 15.53 | 573.10K |
| Sep 22, 2026 | 15.90 | 16.29 | 15.69 | 16.02 | 770.50K |
| Sep 21, 2026 | 15.06 | 15.65 | 14.91 | 15.59 | 1.06M |
About Integra Lifesciences
Integra Lifesciences (IART) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in PRINCETON, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 917520.
IART board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Keith Bradley | Director | May 11, 2026 |
| Shaundra Clay | Director | May 11, 2026 |
| Stuart Essig | President and CEO | Jun 3, 2026 |
| Jeffrey A Graves | Director | May 11, 2026 |
| Barbara B Hill | Director | May 11, 2026 |
| Renee Wonlai Lo | Director | May 11, 2026 |
| Mojdeh Poul | President & CEO | Mar 12, 2026 |
| Christian S Schade | Director | May 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert T. Jr. Davis | EVP & President, TR&DT | Jul 6, 2026 |
| Stuart Essig | President and CEO | Jun 3, 2026 |
| Michael Damon Hutchinson | EVP, Chief Legal Officer & Sec | Mar 12, 2026 |
| Lea Daniels Knight | EVP & Chief Financial Officer | Jul 6, 2026 |
| Michael J. Mcbreen | EVP & Chief Commercial Officer | Jun 3, 2026 |
| Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | Jul 6, 2026 |
| Mojdeh Poul | President & CEO | Mar 12, 2026 |
| Lesha R Shinn | CVP, Chief Legal Officer & Sec | Sep 28, 2026 |
| Harvinder Singh | EVP & President, SS | Jul 6, 2026 |
| Chantal Veillon-Berteloot | EVP & CHRO | Sep 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 5, 2025 | Jeffrey A Graves | Buy | 9,000 | $11.35 |
| Nov 5, 2025 | Jeffrey A Graves | Buy | 9,000 | $11.35 |
| Nov 5, 2025 | Jeffrey A Graves | Buy | 9,000 | $11.35 |
| Nov 5, 2025 | Jeffrey A Graves | Buy | 9,000 | $11.35 |
IART financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.64B | $-516.47M | -6.74 | $50.38M |
| Dec 31, 2024 | $1.61B | $-6.94M | -0.09 | $129.38M |
| Dec 31, 2023 | $1.54B | $67.74M | 0.84 | $139.96M |
| Dec 31, 2022 | $1.56B | $180.55M | 2.16 | $264.47M |
| Dec 31, 2021 | $1.54B | $169.07M | 1.98 | $312.43M |
Latest balance sheet: total assets $3.56B, total liabilities $2.52B, cash $214.41M (as of Jun 30, 2026).
IART earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 2, 2026 | 8-K Item 2.02 (results) | $12.68 |
| Jul 29, 2026 | 8-K Item 2.02 (results) | $16.49 |
| May 5, 2026 | 8-K Item 2.02 (results) | $13.22 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $11.33 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $11.81 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $13.14 |
| May 5, 2025 | 8-K Item 2.02 (results) | $13.28 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $24.72 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $24.12 |
| Jul 29, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IART
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.